Home/Filings/4/0001493152-20-005846
4//SEC Filing

Mohan Pankaj 4

Accession 0001493152-20-005846

CIK 0001106838other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 9:07 PM ET

Size

10.3 KB

Accession

0001493152-20-005846

Insider Transaction Report

Form 4
Period: 2020-04-01
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
  • Award

    Common Stock

    2020-04-01+1,591,1161,591,116 total(indirect: By Mohan Family Office)
  • Award

    Common Stock

    2020-04-01+7,9927,992 total(indirect: By Children)
  • Award

    Warrant to Purchase Common Stock

    2020-04-01+4,2634,263 total(indirect: By Mohan Family Office)
    Exercise: $29.32From: 2020-04-01Exp: 2022-10-14Common Stock (4,263 underlying)
Footnotes (3)
  • [F1]Shares of common stock of the corporation known as Sonnet BioTherapeutics, Inc. ("Sonnet Sub") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 10, 2019, as amended, by and among the Issuer, Sonnet Sub and Biosub Inc., a Delaware corporation (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of Sonnet Sub common stock was exchanged for approximately 0.106572 shares of the Issuer's common stock, subject to adjustment for any reverse stock split. Prior to the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 26 shares of Issuer common stock outstanding and the Issuer changed its name to Sonnet BioTherapeutics Holdings, Inc. All share numbers reflect the reverse stock split.
  • [F2]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.
  • [F3]Prior to the merger, Reporting Person held warrants to purchase 40,000 shares of the common stock of Sonnet Sub at an exercise price of $3.125 per share. Pursuant to the Merger Agreement, these warrants were converted into warrants to purchase 4,263 shares of Issuer common stock (as adjusted for the stock split) at a per share exercise price of $29.32 per share (as adjusted for the stock split).

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001664386

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 9:07 PM ET
Size
10.3 KB